The Japan Patent Office intends to grant bioAffinity a patent for a method tied to its lung test. That may strengthen its protection in Japan, though the patent is not yet granted and no new sales are reported.
That could give bioAffinity more protection for its lung test's prediction method in Japan. The filing reports an intention to grant the patent, not a completed patent or new sales.
Follow bioAffinity Technologies, Inc. (BIAF) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BIAF